SLC22A2 and cancer: The three major debilitating side effects of platinum-based anti-cancer drugs, namely peripheral neurotoxicity19, nephrotoxicity24, 25 and ototoxicity26, are dependent on OCT2-mediated uptake of cisplatin or oxaliplatin in DRGs, renal tubular cells and hair cells of the cochlea, respectively.